🔎 Trials Near Me

Akèy › Skizofreni › New York › New York City

Etid klinik pou Skizofreni nan New York City, NY

13 etid pou Skizofreni ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Ap rekriteEtid obsèvasyon
  • Radial - Manhattan, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07101094

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Ap rekriteFaz 3
  • Neurocrine Clinical Site, New York
  • Neurocrine Clinical Site, New York
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Ap rekriteFaz 3
  • NYU Child Study Center, New York
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Ap rekriteFaz 3
  • Neurocrine Clinical Site, New York
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818

A Study of Brenipatide in Adult Participants With Schizophrenia

Ap rekriteFaz 2
  • Adams Clinical Harlem, New York
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507

52-week Open Label Safety-Tolerability Study

Ap rekriteFaz 3
  • Neuro-Behavioral Clinical Research, New York
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Ap rekriteFaz 2
  • Clinical Site, New York
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Ap rekriteFaz 3
  • Alkermes Investigator Site, New York
Laj 10 a 17 · Tout sèks · Mizajou Aug 14, 2026 · NCT05303064

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

Ap rekrite
  • Manhattan Psychiatric Center, New York
Laj 18 a 64 · Tout sèks · Mizajou Jun 10, 2026 · NCT07434479

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Ap rekriteFaz 4
  • NYU Langone Medical Center, New York
  • New York State Psychiatric Institute, New York
  • Manhattan Psychiatric Center, New York
Laj 18 a 65 · Tout sèks · Mizajou May 4, 2026 · NCT05208190

Study of ALTO-101 in Patients With Schizophrenia

Ap rekriteFaz 2
  • Site 5108, New York
  • Site 5077, New York
Laj 21 a 55 · Tout sèks · Mizajou Dec 26, 2025 · NCT06502964

Effectiveness of Motivation Skills Training (MST)

Ap rekrite
  • The Bridge, Inc., New York
  • New York State Office of Mental Health, New York
Laj 18 a 65 · Tout sèks · Mizajou Nov 5, 2025 · NCT05805397

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

Ap rekrite
  • Zucker Hillside Hospital, New York
Laj 18 a 60 · Tout sèks · Mizajou Sep 25, 2025 · NCT05389787

Etid Skizofreni nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.